跳至主要内容
临床试验/NCT01831258
NCT01831258已完成不适用

Comparison Study of the ICON™ CPAP Series With and Without SensAwake™

Fisher and Paykel Healthcare4 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2013年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
70
试验地点
4
主要终点
Adherence to CPAP Treatment

研究概览

简要总结

Conceptually, awareness of pressure occurs only during wakefulness. Thus reducing the pressure during wakefulness may improve therapy comfort and potentially adherence without compromizing therapy efficacy. SensAwake™ is a unique pressure relief technology developed by Fisher & Paykel Healthcare which detects irregularity in the flow signal indicative of the transition from sleep to wake. When the transition from sleep to wake is detected the device promptly reduces the pressure to help facilitate a return to sleep.

The purpose of this study is to compare adherence and sleep quality outcomes in patients treated by CPAP with and without SensAwake technology.

It is hypothesised that participants with SensAwake on will have improved adherence and sleep quality.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18-75 years with moderate-to-severe OSA (AHI equal to or greater than 10 per hour).
  • Successful in-lab titration polysomnography (PSG)
  • General (at home) sleep habits of:
  • At least 7 hours in bed on most nights
  • Lights out at 12 midnight or earlier
  • Fluency in both written and spoken English.

排除标准

  • Participants prescribed and fitted with any PAP device in the past 2 years
  • Contraindicated for CPAP or AutoCPAP therapy.
  • Any known factor or disease that might interfere with treatment adherence, study conduct or interpretation of the results such as severe psychiatric disease, history of non adherence to medical regimens, or unwillingness to comply with study requirements as determined by the principal investigator.
  • Other significant sleep disorder(s) that would interfere with their ability to wear CPAP as determined by the principal investigator.
  • Patients who are prescribed hypnotics and sedating medications.
  • Any surgery of the mouth, nose, sinuses or airways (for OSA, snoring or otherwise) in the past 12 months.
  • If participants are required, by the nature of their employment, to comply with therapy. For example truck drivers or airline pilots.
  • If the physician objects to their patient taking part in the study.

结局指标

主要结局

Adherence to CPAP Treatment

时间窗: 2 weeks

Average used minutes (all days) taken from the CPAP device.

次要结局

  • OSA Impact of Daily Life(4 weeks)
  • OSA Impact of Daily Life (Fatigue)(4 weeks)
  • Daytime Sleepiness (Subjective Sleep Quality)(4 weeks)
  • Insomnia Severity Index (Subjective Sleep Quality)(4 weeks)
  • Subjective Treatment Efficacy - Patient Global Impression of Change (PGI) - Change(4 weeks)
  • Subjective Treatment Efficacy - Patient Global Impression of Change (PGI) - Severity(4 weeks)

研究者

发起方
Fisher and Paykel Healthcare
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Comparison Study of the ICON™ CPAP Series With and... | 临床试验